Dapcure Pharmaceutical Private Limited
About Dapcure Pharmaceutical Private Limited
Data last updated:
Dapcure Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2020PTC213762.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Daphne Kaur Kandiala (Managing Director) and Sukhvinder Singh Kandiala (Nominee).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Sr.No.64 Shop No.7 Dreams Homes Heera Handewadi Road Hadapsar, Pune, Maharashtra, India – 411028.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.14 Lakh. For the same year it recorded a net profit of ₹1,210 (net margin 0.6%) and EBITDA of ₹26,575 (EBITDA margin 12.4%).
Company details
CIN history
Dapcure Pharmaceutical has one previous CIN (Corporate Identification Number): U24239CT2020OPC009985. The current CIN is U24239PN2020PTC213762, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239PN2020PTC213762 | Current |
| U24239CT2020OPC009985 | Previous |
Contact details
Dapcure Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressSr.No.64 Shop No.7 Dreams Homes Heera Handewadi Road Hadapsar, Pune, Maharashtra, India – 411028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dapcure Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dapcure Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Dapcure Pharmaceutical Private Limited, buy the company report.
Financials of Dapcure Pharmaceutical Private Limited
FY 2022 filings availableDapcure Pharmaceutical Private Limited reported revenue of ₹2.14 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹26,575 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1,210 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 12.4% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Dapcure Pharmaceutical Private Limited, buy the company report.
Board of directors of Dapcure Pharmaceutical Private Limited
Dapcure Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Daphne Kaur Kandiala Also directs: Mapsn Drug Private Limited | Managing Director | 14 Feb 2020 | 6 Years 8 Months | Current |
| Sukhvinder Singh Kandiala Also directs: Mapsn Drug Private Limited | Nominee | 14 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Dapcure Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medi-Marque Lab Private Limited | ₹2.34 Lakh (FY 2024) | -27.0% | Raigarh, Maharashtra, India | |||
| Kra Healthcare (OPC) Private Limited | ₹2.24 Lakh (FY 2025) | -27.0% | Delhi, India | |||
| Koolmon Pharmaceutical Private Limited | ₹2.23 Lakh (FY 2025) | -62.0% | Pune, Maharashtra, India | |||
| Hygeia Bio Science Private Limited | ₹2.18 Lakh (FY 2025) | 1184.0% | Chennai, Tamil Nadu, India | |||
| Care and Sure Biotech Private Limited | ₹2.17 Lakh (FY 2025) | Kadma, Jharkhand, India | ||||
| Dapcure Pharmaceutical Private Limitedthis company | ₹2.14 Lakh (FY 2022) | ₹1,210 | 0.6% | Pune, Maharashtra, India | ||
| Dr. Pande's Med. Remedies (OPC) Private Limited | ₹2.06 Lakh (FY 2025) | -26.0% | Amrvatai, Maharashtra, India | |||
| Sap Medicare (OPC) Private Limited | ₹2.01 Lakh (FY 2025) | Palanpur, Gujarat, India | ||||
| Ain Biotech Private Limited | ₹2 Lakh (FY 2024) | -71.0% | Mumbai, Maharashtra, India | |||
| Inomec Infrastructure Private Limited | ₹2 Lakh (FY 2025) | -96.0% | Bangalore, Karnataka, India | |||
| Dolphin Resins and Paints Pvt Ltd | ₹1.9 Lakh (FY 2025) | 27.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dapcure Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dapcure Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dapcure Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dapcure Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dapcure Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Daphne Kaur Kandiala was appointed as Managing Director on 14 Feb 2020.
Frequently asked questions
Dapcure Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2020 (6+ years old) and is registered under CIN U24239PN2020PTC213762.
Dapcure Pharmaceutical has 2 current directors:
- Daphne Kaur Kandiala - Managing Director
- Sukhvinder Singh Kandiala - Nominee
The latest financial statements of Dapcure Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Dapcure Pharmaceutical is U24239PN2020PTC213762. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dapcure Pharmaceutical was incorporated on 14 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Dapcure Pharmaceutical by revenue are Medi-Marque Lab Private Limited, Kra Healthcare (OPC) Private Limited, Koolmon Pharmaceutical Private Limited, Hygeia Bio Science Private Limited, Care and Sure Biotech Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Daphne Kaur Kandiala was appointed as Managing Director on 14 Feb 2020. Sukhvinder Singh Kandiala was appointed as Nominee on 14 Feb 2020.
The registered office of Dapcure Pharmaceutical is at Sr.No.64 Shop No.7 Dreams Homes Heera Handewadi Road Hadapsar, Pune, Maharashtra, India – 411028.
Dapcure Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dapcure Pharmaceutical can be reached at its registered office: Sr.No.64 Shop No.7 Dreams Homes Heera Handewadi Road Hadapsar, Pune, Maharashtra, India – 411028.
Dapcure Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.